Search

Search any products, services and so on here.

About 16311 result(s)

Global Raltegravir Potassium Drugs Market Research Report 2024

  • Sep 18, 24
  • ID: 553636
  • Pages: 73
  • Figures: 75
  • Views: 0
  • From $2,900

Raltegravir potassium is human immunodeficiency virus integrase strand transfer inhibitors,which is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adult patients. The global Raltegravir Potassium Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-203...


Global Letermovir Tablets Market Research Report 2024

  • Sep 18, 24
  • ID: 553635
  • Pages: 69
  • Figures: 73
  • Views: 0
  • From $2,900

Letermovir tablets are an antiviral medication used to prevent cytomegalovirus (CMV) infection in patients undergoing stem cell or organ transplantation. The global Letermovir Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North American market for Letermovir Tablets is estimated to incr...


Global Letermovir Drugs Market Research Report 2024

  • Sep 18, 24
  • ID: 553634
  • Pages: 71
  • Figures: 73
  • Views: 0
  • From $2,900

Letermovir is an antiviral drug used primarily to prevent cytomegalovirus (CMV) infection in immunocompromised patients, such as those undergoing stem cell or organ transplantation.By inhibiting a viral enzyme, known as the CMV terminase complex, letermovir prevents the virus from multiplying and spreading within the body. The global Letermovir Drugs market was valued at US$ million in 2023 and i...


Global Cladribine API Market Research Report 2024

  • Sep 18, 24
  • ID: 553633
  • Pages: 96
  • Figures: 92
  • Views: 0
  • From $2,900

Cladribine API is a key component used in medications to treat certain cancers and autoimmune disorders. It is a purine analog that disrupts DNA synthesis by mimicking natural purines and integrating into the DNA strand. The global Cladribine API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. Nor...


Global Diazepam Nasal Spray Market Research Report 2024

  • Sep 18, 24
  • ID: 553632
  • Pages: 67
  • Figures: 70
  • Views: 0
  • From $2,900

Diazepam nasal spray is a medication designed to provide rapid relief from acute seizures, particularly in individuals with epilepsy. It contains diazepam, a benzodiazepine that works by enhancing the effects of a neurotransmitter called gamma-aminobutyric acid (GABA) in the brain, which helps to calm abnormal electrical activity and stop seizures. The global Diazepam Nasal Spray market was valued...


Global Linezolid for Oral Suspension Market Research Report 2024

  • Sep 18, 24
  • ID: 553631
  • Pages: 72
  • Figures: 67
  • Views: 0
  • From $2,900

Linezolid for oral suspension is an antibiotic used to treat various bacterial infections, including those caused by resistant strains like methicillin-resistant Staphylococcus aureus (MRSA). The global Linezolid for Oral Suspension market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North American m...


Global Ropinirole Hydrochloride Tablets Market Research Report 2024

  • Sep 18, 24
  • ID: 553630
  • Pages: 75
  • Figures: 74
  • Views: 0
  • From $2,900

Ropinirole hydrochloride tablets are a medication commonly prescribed to manage symptoms of Parkinson's disease and restless legs syndrome (RLS). As a dopamine agonist, ropinirole works by stimulating dopamine receptors in the brain, which helps improve motor control and reduce symptoms associated with these conditions. The global Ropinirole Hydrochloride Tablets market was valued at US$ million...


Global Entacapone Tablets Market Research Report 2024

  • Sep 18, 24
  • ID: 553629
  • Pages: 95
  • Figures: 93
  • Views: 0
  • From $2,900

Entacapone tablets are a medication used primarily to treat Parkinson's disease and other movement disorders. They work by inhibiting the enzyme catechol-O-methyltransferase (COMT), which breaks down dopamine in the brain. The global Entacapone Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-20...


Global Entacapone,Levodopa and Carbidopa Tablets Market Research Report 2024

  • Sep 18, 24
  • ID: 553628
  • Pages: 74
  • Figures: 74
  • Views: 0
  • From $2,900

Entacapone, levodopa, and carbidopa tablets are a combination medication used to treat Parkinson's disease and Parkinsonism symptoms. The global Entacapone,Levodopa and Carbidopa Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North American market for Entacapone,Levodopa and Carbidopa T...


Global Ondansetron Hydrochloride Tablets Market Research Report 2024

  • Sep 18, 24
  • ID: 553627
  • Pages: 90
  • Figures: 97
  • Views: 0
  • From $2,900

Ondansetron hydrochloride tablets are oral medications used to prevent and treat nausea and vomiting, especially those associated with chemotherapy, radiation therapy, and post-surgery. The global Ondansetron Hydrochloride Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North American mark...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232